Skip to content

Mesoridazine

Phenothiazine — NERVOUS SYSTEM

Also known as: mesoridazine besilate, mesoridazine besylate, thioridazine-2-sulfoxide

OfmFDA approvedATC N05AC03

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Mesoridazine is an ofm drug in the Phenothiazine class catalogued in DrugCentral. It was first approved by the FDA in 1970. DrugCentral lists 15 molecular targets, including HRH1, DRD3 and HTR2A. Recorded indications include Schizophrenia.

  • Approval status: ofm (first approved 1970 by the FDA).
  • Drug class: Phenothiazine.
  • Molecular targets: HRH1, DRD3, HTR2A and DRD4 (15 listed in DrugCentral).
  • Indications: Schizophrenia.
  • ATC code: N05AC03 (Phenothiazines with piperidine structure).
  • Molecular formula: C21H26N2OS2; molecular weight 386.57 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Schizophrenia

Contraindications (13)

  • Coma
  • Conduction disorder of the heart
  • Congenital long QT syndrome
  • Epilepsy
  • Granulocytopenic disorder
  • Hyperkalemia
  • Hypokalemia
  • Neuroleptic malignant syndrome
  • Orthostatic hypotension
  • Predisposed to Torsades de Pointes Cardiac Arrhythmias
  • Prolonged QT interval
  • Stupor
  • Tardive dyskinesia

Mechanism & targets

Established pharmacologic classPhenothiazine

Molecular targets (15)

TargetGeneActionActivity
Histamine H1 receptorHRH1unknownKi 8.74
D(3) dopamine receptorDRD3unknownKi 8.59
5-hydroxytryptamine receptor 2AHTR2AantagonistKi 8.12
D(4) dopamine receptorDRD4unknownKi 8.04
Muscarinic acetylcholine receptor M1CHRM1unknownKi 8.00
Muscarinic acetylcholine receptor M2CHRM2unknownKi 7.82
D(2) dopamine receptorDRD2antagonistKi 7.72
Muscarinic acetylcholine receptor M4CHRM4unknownKi 7.72
Muscarinic acetylcholine receptor M5CHRM5unknownKi 7.22
Muscarinic acetylcholine receptor M3CHRM3unknownKi 7.05
D(1A) dopamine receptorDRD1antagonistKi 6.99
5-hydroxytryptamine receptor 1AHTR1AantagonistKi 6.98
5-hydroxytryptamine receptor 2CHTR2CunknownKi 6.80
Potassium voltage-gated channel subfamily H member 2KCNH2unknownIC50 6.50
5-hydroxytryptamine receptor 6HTR6unknownKi 6.42

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1970-02-27FDA——

ATC classification

ATC codeTherapeutic hierarchy
N05AC03NERVOUS SYSTEM › PSYCHOLEPTICS › ANTIPSYCHOTICS › Phenothiazines with piperidine structure

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Mesoridazine is on its molecule page.

Molecular formulaC21H26N2OS2
Molecular weight386.57 g/mol
CAS number5588-33-0
InChIKeySLVMESMUVMCQIY-UHFFFAOYSA-N
PubChem CID4078
CN1CCCCC1CCN1C2=CC=CC=C2SC2=C1C=C(C=C2)S(C)=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Mesoridazine used for?

DrugCentral lists the following indications for Mesoridazine: Schizophrenia.

How does Mesoridazine work?

Its molecular targets in DrugCentral include HRH1, DRD3, HTR2A (antagonist) and DRD4.

When was Mesoridazine first approved?

Mesoridazine was first approved by the FDA in 1970.

What drug class does Mesoridazine belong to?

Mesoridazine is in the Phenothiazine class.

What is the chemical formula of Mesoridazine?

Mesoridazine has the molecular formula C21H26N2OS2 and a molecular weight of 386.57 g/mol.

Browse: all drugs starting with M · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFM
First approval1970-02-27
AgencyFDA
Targets15
Indications1
FormulaC21H26N2OS2
DrugCentral ID1712
Interactive profile